PTPI

Petros Pharmaceuticals, Inc. [PTPI] Stock Forecast

Q: What is Petros Pharmaceuticals, Inc. stock symbol ?

Petros Pharmaceuticals, Inc. is a US stock, located in New york of Ny and trading under the symbol PTPI

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

PTPI Stock Summary

In the last year, shareholders have seen their holdings diluted. Dilution over past year is 111.34%

Earnings are expected to fall -100% next year

Does not have any significance market cap ($5.18M)

Profit margins (-39.61%) are lower than the previous year (-4.51%)

PTPI has less than 1 year of cash runway

Top 10 Correlated ETFs

PTPI

Top 10 Correlated Stocks

PTPI

In the News

06:00 08 Jun 2023 PTPI

Top Penny Stocks Chart Patterns to Use to Profit

Use these top charts to profit with penny stocks The post Top Penny Stocks Chart Patterns to Use to Profit appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

06:00 08 Jun 2023 PTPI

Penny Stock Due Diligence: Top Research Techniques

Use these tips for researching penny stocks in 2023 The post Penny Stock Due Diligence: Top Research Techniques appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

06:00 08 Jun 2023 PTPI

Buying Energy Penny Stocks? 3 Methods to Use

Investing in energy penny stocks? Here's some top tips The post Buying Energy Penny Stocks?

09:25 08 Jun 2023 PTPI

Petros Pharmaceuticals to Present at the Planet MicroCap Showcase 2022

NEW YORK, April 27, 2022 (GLOBE NEWSWIRE) -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men's health, announces today that President and Chief Commercial Officer Fady Boctor will present virtually at the Planet MicroCap Showcase 2022. The conference is being held on May 3 – 5, 2022 at The Bally's Hotel & Casino in Las Vegas, NV.

04:30 08 Jun 2023 PTPI

3 Hot Penny Stocks to Add to Your Small-Caps Watch List This Week

Can these penny stocks climb this coming week? The post 3 Hot Penny Stocks to Add to Your Small-Caps Watch List This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

11:30 08 Jun 2023 PTPI

Best Penny Stocks, How To Buy & Strategies for Beginners

Are these strategies on your list for buying penny stocks next month? The post Best Penny Stocks, How To Buy & Strategies for Beginners appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

03:41 08 Jun 2023 PTPI

What Are Penny Stocks? What You Need to Know and 3 to Watch

Check these three penny stocks out for your watchlist The post What Are Penny Stocks? What You Need to Know and 3 to Watch appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

08:00 08 Jun 2023 PTPI

Petros Pharmaceuticals to Present at the Q1 Investor Summit Conference

NEW YORK, March 03, 2022 (GLOBE NEWSWIRE) -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men's health, announces today that President and Chief Commercial Officer Fady Boctor will present a corporate overview at the Q1 Investor Summit Conference, which is being held virtually on March 8 – 9, 2022.

11:04 08 Jun 2023 PTPI

Best Penny Stocks To Buy This Week? 4 Short Squeeze Stocks To Watch

Are short squeeze penny stocks part of your strategy this week? The post Best Penny Stocks To Buy This Week?

03:33 08 Jun 2023 PTPI

3 Reddit Penny Stocks For Your Watch List In January 2022

Reddit penny stocks to watch this week. The post 3 Reddit Penny Stocks For Your Watch List In January 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

PTPI Financial details

Company Rating

Neutral

Market Cap

5.18M

Income

-239.42M

Revenue

6.04M

Book val./share

7.4

Cash/share

3.98

Dividend

Dividend %

Employees

Optionable

Shortable

Yes

Earnings

17 May 2021

P/E

-0.02

Forward P/E

PEG

P/S

0.81

P/B

0.31

P/C

0.57

P/FCF

-0.59

Quick Ratio

1.56

Current Ratio

2.02

Debt / Equity

0.98

LT Debt / Equity

0.53

EPS (TTM)

-112.67

EPS next Y

EPS next Q

EPS this Y

-119.1%

EPS next Y

EPS next 5Y

EPS last 5Y

Revenue last 5Y

Revenue Q/Q

215.5%

EPS Q/Q

5251900%

SMA20

-50%

SMA50

100%

SMA100

-33.33%

Inst Own

1.49%

Inst Trans

-0.4%

ROA

-783%

ROE

-1100%

ROC

-0.88%

Gross Margin

61%

Oper. Margin

-343%

Profit Margin

-3961%

Payout

Shs Outstand

2.11M

Shs Float

1.48M

Target Price

52W Range

0.917-28.8

52W High

52W Low

RSI

Rel Volume

0.01

Avg Volume

2.61M

Volume

16.54K

Perf Week

-6.94%

Perf Month

-47.22%

Perf Quarter

12.87%

Perf Half Y

-37.53%

Beta

1.82052

Volatility

0.07%, 0.79%

Prev Close

-1.72%

Price

2.28

Change

-4.2%

PTPI Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric	2019-12-31	2020-12-31	2021-12-31	2022-12-31
Revenue per share	16.05	17.9	7.17	0
Net income per share	-33.49	-38.55	0.07	-0.01
Operating cash flow per share	2.61	-28.66	-10.89	-0.01
Free cash flow per share	2.54	-28.67	-10.89	-0.01
Cash per share	2.21	32.09	21.9	0
Book value per share	8.26	32.71	32.64	0.01
Tangible book value per share	-31.72	-27.51	9.41	-12.21
Share holders equity per share	8.26	32.71	32.64	0.01
Interest debt per share	28.42	19.15	0.71	0
Market cap	38.73M	23.5M	36.26M	4.82B
Enterprise value	50.33M	13.53M	12.82M	4.82B
P/E ratio	-1.19	-1.14	485.68	-178.4
Price to sales ratio	2.49	2.46	4.64	805
POCF ratio	15.29	-1.54	-3.06	-376.92
PFCF ratio	15.74	-1.53	-3.06	-376.92
P/B Ratio	4.83	1.35	1.02	288.8
PTB ratio	4.83	1.35	1.02	288.8
EV to sales	3.23	1.42	1.64	805.05
Enterprise value over EBITDA	-4.35	-1.27	-1.15	-704.97
EV to operating cash flow	19.87	-0.88	-1.08	-376.95
EV to free cash flow	20.45	-0.88	-1.08	-376.95
Earnings yield	-0.84	-0.88	0	-0.01
Free cash flow yield	0.06	-0.65	-0.33	0
Debt to equity	6.28	3	0.9	0.94
Debt to assets	0.86	0.75	0.47	0.48
Net debt to EBITDA	-1	0.94	2.1	-0.05
Current ratio	0.29	0.62	0.99	2.08
Interest coverage	-1.22	-5.66	-48.96	-26.59
Income quality	-0.08	0.74	1.32	0.64
Dividend Yield	0	0	0	0
Payout ratio	0	0	0	0
Sales general and administrative to revenue	0	0	0	0
Research and developement to revenue	0	0.05	0.23	0.29
Intangibles to total assets	0.66	0.46	0.38	0.38
Capex to operating cash flow	-0.03	0	0	0
Capex to revenue	0	0	0	0
Capex to depreciation	-0.01	0	0	0
Stock based compensation to revenue	0	0	0.17	0.2
Graham number	78.9	168.43	7.1	0.05
ROIC	-0.33	-0.54	0.01	-1.82
Return on tangible assets	-1.66	-0.55	0	-1.34
Graham Net	-45.54	-58.05	-4.99	0
Working capital	-29.02M	-15.99M	-437.38K	7.6M
Tangible asset value	-30.79M	-14.69M	10.25M	4.46M
Net current asset value	-38.26M	-26.48M	-1.3M	-1.05M
Invested capital	1.71	0.41	0.01	0.58
Average receivables	0	4.5M	4.11M	2.59M
Average payables	0	4.69M	5.08M	3.18M
Average inventory	0	1.48M	640.09K	1.17M
Days sales outstanding	90.17	196.75	143.19	128.54
Days payables outstanding	185.59	505.99	1.04K	287.99
Days of inventory on hand	108.34	68.6	118.58	289.38
Receivables turnover	4.05	1.86	2.55	2.84
Payables turnover	1.97	0.72	0.35	1.27
Inventory turnover	3.37	5.32	3.08	1.26
ROE	-4.05	-1.18	0	-1.62
Capex per share	-0.07	-0.01	0	0

Quarterly Fundamentals Overview

Last date of statement is 2023-03-31 for Q1

Metric	2022-03-31	2022-06-30	2022-09-30	2022-12-31	2023-03-31
Revenue per share	1.19	2.02	-0.7	0	1.21
Net income per share	1.7	-0.95	-6.68	0	-105.04
Operating cash flow per share	-2.55	-2.03	-0.85	0	-0.36
Free cash flow per share	-2.55	-2.03	-0.85	0	-0.36
Cash per share	8.54	6.43	5.4	0	3.98
Book value per share	17.27	16.54	10	0.01	7.4
Tangible book value per share	17.27	5.82	3.64	-12.21	-5.46K
Share holders equity per share	17.27	16.54	10	0.01	7.4
Interest debt per share	5.19	5.08	4.89	0	4.54
Market cap	32.27M	17.37M	10.55M	4.82B	2.91M
Enterprise value	25.17M	14.44M	9.33M	4.82B	3.94M
P/E ratio	2.29	-2.21	-0.19	-285.67	0
Price to sales ratio	13.09	4.15	-7.24	6.04K	1.16
POCF ratio	-6.12	-4.14	-6.03	-3.07K	-3.89
PFCF ratio	-6.12	-4.14	-6.03	-3.07K	-3.89
P/B Ratio	0.9	0.51	0.51	288.8	0.19
PTB ratio	0.9	0.51	0.51	288.8	0.19
EV to sales	10.21	3.45	-6.4	6.04K	1.56
Enterprise value over EBITDA	23.31	-143.58	-2.01	-1.52K	-9.46
EV to operating cash flow	-4.77	-3.44	-5.33	-3.07K	-5.26
EV to free cash flow	-4.77	-3.44	-5.33	-3.07K	-5.26
Earnings yield	0.11	-0.11	-1.31	0	-75.3
Free cash flow yield	-0.16	-0.24	-0.17	0	-0.26
Debt to equity	0.56	0.49	0.82	0.94	0.98
Debt to assets	0.36	0.33	0.45	0.48	0.49
Net debt to EBITDA	-6.58	29.18	0.26	-0.1	-2.46
Current ratio	2.61	3.1	2.36	2.08	2.02
Interest coverage	-3.14	-11.05	-92.58	-28.29	-9.21
Income quality	30.28	2.32	0.13	0.37	0.54
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0
Sales general and administrative to revenue	0	0	0	0	0
Research and developement to revenue	0.16	0.1	-0.5	0.22	0.13
Intangibles to total assets	0.42	0.43	0.35	0.38	0.37
Capex to operating cash flow	0	0	0	0	0
Capex to revenue	0	0	0	0	0
Capex to depreciation	0	0	0	0	0
Stock based compensation to revenue	0.14	0.07	-0.21	0.29	0.05
Graham number	25.73	18.79	38.78	0.02	132.21
ROIC	0.58	-0.08	-1.03	-0.35	-17.18
Return on tangible assets	0.11	-0.07	-0.56	-0.21	-11.46
Graham Net	0.85	0.87	-0.9	0	-1.91
Working capital	16.55M	15.48M	10.83M	7.6M	7.02M
Tangible asset value	11.99M	12.04M	7.54M	4.46M	4.03M
Net current asset value	6.7M	6.02M	1.77M	-1.05M	-1.22M
Invested capital	0.3	0.3	0.48	0.58	0.6
Average receivables	3.4M	5.1M	4.84M	2.97M	2.25M
Average payables	4.13M	2.8M	1.99M	1.95M	1.83M
Average inventory	1.23M	1.93M	2.03M	1.98M	1.93M
Days sales outstanding	158.81	125.8	-236.91	237.97	85.77
Days payables outstanding	705.06	264.02	654.77	184.47	303.68
Days of inventory on hand	370.2	264.62	676.6	185.36	333
Receivables turnover	0.57	0.72	-0.38	0.38	1.05
Payables turnover	0.13	0.34	0.14	0.49	0.3
Inventory turnover	0.24	0.34	0.13	0.49	0.27
ROE	0.1	-0.06	-0.67	-0.25	-14.2
Capex per share	0	0	0	0	0

PTPI Frequently Asked Questions

What is Petros Pharmaceuticals, Inc. stock symbol ?

Petros Pharmaceuticals, Inc. is a US stock , located in New york of Ny and trading under the symbol PTPI

What is Petros Pharmaceuticals, Inc. stock quote today ?

Petros Pharmaceuticals, Inc. stock price is $2.28 today.

Is Petros Pharmaceuticals, Inc. stock public?

Yes, Petros Pharmaceuticals, Inc. is a publicly traded company.

Something similar

Top by Market Cap

Top Correlated ETFs

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 2.61M
Market Capitalization 5.18M
Employee 24
CEO Mr. John D. Shulman
Headquarters New York,NY,US
IPO Date 2020-12-02
Website https://www.petrospharma.com

Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a patented topical formulation candidate for the treatment of acute Peyronie's disease. The company markets its line of ED products in the form of vacuum erection device products. Petros Pharmaceuticals, Inc. is based in New York, New York.